FOXD2 and thyroid cancer: Overexpression of FOXD2-AS1 was found to significantly correlate with age, T classification, N classification, clinical stage, and recurrence status in thyroid cancer patients via analyzing clinical dataset of thyroid cancer patients from TCGA (Table 3).